Status: Not yet recruiting
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
The purpose of this study is to learn about the safety and effectiveness of berobenatide in adults with overweight or obesity who have already lost weight while taking semaglutide or tirzepatide. The study does not include people with diabetes. Participants will be in the study for about 11 months.
Participants needed: 660
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: PfizerUpdated: Sep 29, 2026Locations: 8
Eligibility criteria
Aged ≥18 years. [+1]
Diagnosis of any form of diabetes. [+2]